ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

Rosen Law Firm has filed a class action lawsuit against ADMA Biologics, Inc. on behalf of investors who purchased securities between August 9, 2024 and March 25, 2026. The lawsuit alleges that ADMA engaged in undisclosed related party transactions, channel stuffing, lacked adequate internal controls, and made materially false statements about its business operations. Investors have until August 10, 2026 to move the court to serve as lead plaintiff.